Kang, S.; Sunwoo, K.; Jung, Y.; Hur, J.K.; Park, K.-H.; Kim, J.S.; Kim, D.
Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics 2020, 9, 758.
https://doi.org/10.3390/antibiotics9110758
AMA Style
Kang S, Sunwoo K, Jung Y, Hur JK, Park K-H, Kim JS, Kim D.
Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics. 2020; 9(11):758.
https://doi.org/10.3390/antibiotics9110758
Chicago/Turabian Style
Kang, Sangrim, Kyoung Sunwoo, Yuna Jung, Junho K. Hur, Ki-Ho Park, Jong Seung Kim, and Dokyoung Kim.
2020. "Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA)" Antibiotics 9, no. 11: 758.
https://doi.org/10.3390/antibiotics9110758
APA Style
Kang, S., Sunwoo, K., Jung, Y., Hur, J. K., Park, K. -H., Kim, J. S., & Kim, D.
(2020). Membrane-Targeting Triphenylphosphonium Functionalized Ciprofloxacin for Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics, 9(11), 758.
https://doi.org/10.3390/antibiotics9110758